Clayton, NC, United States of America

Joey Roger Thomas

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Clayton, NC (US) (2019 - 2023)
  • Research Triangle Park, NC (US) (2019 - 2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Joey Roger Thomas

Introduction

Joey Roger Thomas is an accomplished inventor based in Clayton, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing topical compositions for dermatological conditions. With a total of six patents to his name, Thomas continues to push the boundaries of innovation in his field.

Latest Patents

Among his latest patents, Thomas has developed topical pharmaceutical emulsion compositions that include a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof. These compositions consist of an oil phase, a water phase, a surfactant, and an antioxidant, ensuring that the emulsion is homogeneous and that the active ingredient is solubilized in the oil phase. The invention also outlines methods for treating dermatological conditions or disorders by administering these compositions to the skin of patients.

Career Highlights

Joey Roger Thomas is currently associated with Dermavant Sciences GmbH, where he applies his expertise in pharmaceutical innovations. His work focuses on creating effective treatments that enhance patient care and improve health outcomes.

Collaborations

Thomas collaborates with notable colleagues, including Sujatha D Sonti and Jon Lenn, to further advance the research and development of innovative pharmaceutical solutions.

Conclusion

Joey Roger Thomas exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight his commitment to improving dermatological treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…